Back to Search
Start Over
Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.
- Source :
-
Nature cancer [Nat Cancer] 2022 Nov; Vol. 3 (11), pp. 1404. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 2662-1347
- Volume :
- 3
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Nature cancer
- Accession number :
- 36376510
- Full Text :
- https://doi.org/10.1038/s43018-022-00487-7